Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

(RTTNews) - Medicus Pharma Ltd. (MDCX) Thursday announced positive results from the interim analysis of Phase 2 study of SKNJCT-003 to non-invasively treat basal cell carcinoma of the skin (BCC).

Researchers studied the efficacy and safety of dermatologic surgery for keratinocyte skin cancer among patients aged 80 years and older.

Source: Getty Images At an early stage, basal cell carcinoma is small and confined, and usually can be cured. When the cancer gets larger and grows deeper in the skin or spreads to other organs ...

Jan. 27, 2025 — Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to ...

In a small study in a community oncology practice, more than 60% of patients with advanced squamous cell skin cancer treated ...

For Black people, surviving skin cancer begins with knowing what to look for—and where. Hint: It often shows up where the sun ...

Researchers at Karolinska Institutet, led by Dr. Helin Norberg and Dr. Erik Norberg, have identified a previously unknown ...

Solid tumors often provide a challenging environment for the T cells of our immune system. By reprogramming the metabolism of ...

Compared with other ablative therapies, stereotactic body radiotherapy might offer a ‘particularly advantageous option’ for ...

A dermatology expert panel confirms image-guided superficial radiation therapy as a safe, effective first-line treatment for ...

Metabolic cell death represents a rapidly evolving and intricate field within cancer research. Recent studies have elucidated ...